What corporation is involved with the colon cancer gene research?

Bioniche Life Sciences Inc.





PO Box 1570


Belleville, Ontario


K8N 5J2


Canada


Tel: (613) 9668058


Fax: (613)9664177





Bioniche Life Sciences Inc presented data from a study using the company's proprietary Mycobacterial Cell Wall-DNA Complex (MCC) against peritoneal (colon) cancer in rats. The data was presented at the 7th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The study, co-authored by Dr Nigel C Phillips, Chief Scientific Officer and Dr Mario C Filion, Head of Biomedical Research at Bioniche Life Sciences, evaluated the in vitro activity of MCC against DHD/K12/PROb cells, and the in vivo activity of MCC against DHD/K12/PROb peritoneal carcinomatosis in rats. Dr Filion stated that MCC has direct anticancer activity against PROb cells, as demonstrated by its ability to inhibit proliferation and induce apoptosis. Dr Phillips added that repeated intraperitoneal injection of MCC was well tolerated in non-cancer bearing animals. Significant anticancer activity was seen following tumour cell injection and subsequent treatment with MCC (greater than 350% increase in median survival time at day 200) with substantially more treated animals surviving when compared to the control treated animals. Anticancer activity continues to be maintained at day 278 (greater than 480% increase in media survival time), demonstrating the ability of MCC to induce long-duration remission of disease. Bioniche Life Sciences Inc is a research-based, technology-driven Canadian biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.

What corporation is involved with the colon cancer gene research?
Here are some articles.


This one is for clinical trials: http://clinicaltrials.gov/search/term=(N...





while the one below is a scientific article about research done recently.

baby teeth